Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3333545

FC1(F)CCN(C2CCNCC2)C1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33
CD38 P28907 1/20 0.33
CCRL2 O00421 1/20 0.33
CHRM2 P08172 3/20 0.33
CHRM1 P11229 3/20 0.33
CHRM3 P20309 3/20 0.33
PLAT P00750 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
DPP4 P27487 2/20 0.32
DPP7 Q9UHL4 2/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2372681 0.86 DPP4 (0.37) PLATHRH3DPP4DPP7DPP8
Hydrochloric Acid SCHEMBL23884910 0.84 DPP4 (0.36) PLATHRH3DPP4DPP7DPP8
Hydrochloric Acid SCHEMBL3606485 0.84 DPP4 (0.36) PLATHRH3DPP4DPP7DPP8
Trifluoroacetic Acid SCHEMBL29823097 0.79 HPGD (0.40) ARG1ARG2HRH3GABRPGABRD
Trifluoroacetic Acid SCHEMBL5901557 0.78 L3MBTL3 (0.35) ARG1ARG2CHRM2CHRM1CHRM3
Trifluoroacetic Acid SCHEMBL994467 0.76 GABRP (0.35) ARG1ARG2HRH3GABRPGABRD
Trifluoroacetic Acid SCHEMBL28252483 0.76 PKM (0.33) ARG1ARG2HRH3PKMHRH4
SCHEMBL29090720 0.76 IRAK4 (0.37) HRH3DPP4DPP7DPP8DPP9
Trifluoroacetic Acid SCHEMBL30567860 0.75 L3MBTL3 (0.49) HRH3TSHRL3MBTL3L3MBTL1
SCHEMBL521969 0.75 HRH3 (0.39) PLATHRH3L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137305-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-03 US disclosed
EP-2142537-A2 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2010-01-13 EP disclosed
WO-2008115973-A2 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137305-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS AURKC, AURKA, AURKB ARG1 3916/4885ARG2 2710/4885CD38 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.